Global Microneedle Drug Delivery Systems Market
市场规模（十亿美元）
CAGR :
% 
 Forecast Period |
2022 –2029 |
 Market Size (Base Year) |
USD 5.99 Billion |
 Market Size (Forecast Year) |
USD 10.76 Billion |
 CAGR |
% |
| Major Markets Players |
>全球微针药物输送系统市场，按技术（空心、多孔、固体、其他）、来源类型（硅、金属、聚合物、多糖、其他）、应用（心血管、肿瘤学、皮肤病学、神经病学、其他）、最终用户（诊断实验室、生命科学和研究实验室、医院、门诊手术中心、其他）划分 - 行业趋势和预测到 2029 年。
全球微针药物输送系统市场分析及规模
药物输送系统技术进步和产品创新的不断进步促成了微针药物输送系统的发明。该药物输送系统主要用于糖尿病患者。在印度，果阿邦的糖尿病患病率最高，其次是安达曼和尼科巴群岛。
- Data Bridge Market Research 分析称，预测期内，微针给药系统市场预计将经历 7.60% 的复合年增长率。这意味着 2021 年的 59.9 亿美元市场价值将在 2029 年飙升至 107.6 亿美元。由于全球糖尿病患者基数不断增加，“Hollow”在微针给药系统市场的技术领域占据主导地位。Data Bridge Market Research 团队策划的市场报告包括深入的专家分析、患者流行病学、渠道分析、定价分析和监管框架。
全球微针药物输送系统市场定义
从名称本身就可以看出，微针药物输送系统是一种药物输送技术，涉及使用微小的针头将药物注射到体内。微针比传统针头具有更大的优势。微针以阵列形式排列在微小的贴片上，为患者提供治疗效果。
报告范围和市场细分
|
报告指标 |
细节 |
|
预测期 |
2022 至 2029 年 |
|
基准年 |
2021 |
|
历史岁月 |
2020（可定制至 2019 - 2014） |
|
定量单位 |
收入（单位：十亿美元）、销量（单位：台）、定价（美元） |
|
涵盖的领域 |
技术（空心、多孔、固体、其他）、来源类型（硅、金属、聚合物、多糖、其他）、应用（心血管、肿瘤学、皮肤病学、神经病学、其他）、最终用户（诊断实验室、生命科学和研究实验室、医院、门诊手术中心、其他） |
|
覆盖国家 |
U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America. |
|
Market Players Covered |
Abbott (US), Siemens Healthineers AG (Germany), Quidel Corporation (US), F. Hoffman-La Roche Ltd. (Switzerland), Danaher. (US), BD (US), Chembio Diagnostics (US), EKF Diagnostics (UK), Trinity Biotech plc (Ireland), Instrumentation Laboratory (US), Nova Biomedical (US), PTS Diagnostics (US), Sekisui Diagnostics (US), Thermo Fisher Scientific (US), bioMérieux S.A. (France), DiaSorin S.p.A (Italy), AccuBioTech Co., Ltd. (China), Meridian Bioscience (US), Biocartis Bioscience (Europe), GeneSTAT Molecular Diagnostics, LLC (US), Terumo Corporation (Japan) and Grifols, S.A (Spain) |
|
Market Opportunities |
|
Microneedle Drug Delivery Systems Market Dynamics
Drivers
- Rising prevalence of obesity
Growing population base of overweight and obese individuals globally is one of the major factor fostering the growth of the market. India, Germany, China, United States and United Kingdom have the highest obese population base in the world. Obesity gives rise to numerous problems in the body. Respiratory problems, diabetes and other chronic and acute diseases are some of the examples.
- Research and development proficiencies
Rising expenditure for research and development proficiencies especially in the developed and developing economies pertaining to the medical instruments and devices will further create lucrative market growth opportunities. Research and development proficiencies being conducted to provide best of the medications to curb obesity is also bolstering the market growth rate.
- Growing investment for healthcare facilities
Surging focus towards improving the condition of healthcare facilities and improving the overall healthcare infrastructure another important factor fostering the growth of the market. Rising number of partnerships and strategic collaborations between the public and private players pertaining to funding and application of new and improved technology is further creating lucrative market opportunities.
Opportunities
Furthermore, upsurge in the public-private funding for target research activities, rising awareness about the negative impact of obesity on the body, growing prevalence of acute and chronic diseases, rising geriatric population base and rising product innovations and development owing to technological advancements all around the world will extend profitable opportunities for the market players in the forecast period of 2022 to 2029. Additionally, availability of safer alternatives to the conventional hypodermic injection, rising demand for minimally invasive drug delivery systems, rising internet penetration rate, growing number of cardiovascular diseases and increasing per capita expenditure on health care will further expand the market's growth rate in the future.
Restraints/Challenges Global Microneedle Drug Delivery Systems Market
On the other hand, high cost associated with the research and development proficiencies, limited infrastructural facilities, uneven distribution of medical services, rising interest in alternate routes of drug administration transdermal and intradermal drug delivery systems and dearth of awareness in the backward economies are expected to obstruct market growth. Also, lack of favorable reimbursement scenario and technology penetration in the developing economies, poor absorption and changeability in absorption, limited insurance coverage and regulatory compliance, and lack of suitable infrastructure in low- and middle-income countries are projected to challenge the market in the forecast period of 2022-2029.
This microneedle drug delivery systems market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the microneedle drug delivery systems market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.
COVID-19 Impact on Microneedle Drug Delivery Systems Market
COVID-19 had a negative impact on the market. The supply chain disruptions created challenges for the transportation and distribution of drug delivery systems and equipment. Also, restrictions imposed on the movement further created hindrances. Subsequent fall in the demand and supply of non- important medical devices and equipment further created hindrances for the market. However, owing to the rising number of patients on daily basis and large number of treatment procedures on hold, there is a huge scope of growth post the pandemic.
Recent Developments
- In May 2021, BD announced that it will construct a new drug delivery manufacturing facility in Spain which will help to produce the drug delivery devices for the European market to deliver the biological drugs.
Global Microneedle Drug Delivery Systems Market Scope
The microneedle drug delivery systems market is segmented on the basis of technology, source type, application and end users. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.
Technology
- Hollow
- Porous
- Solid
- Others
On the basis of technology, the microneedle drug delivery systems market is segmented into hollow, porous, solid and others.
Source type
- Silicon
- Metals
- Polymers
- Polysaccharides
- Others
On the basis of source type, the microneedle drug delivery systems market is segmented into silicon, metals, polymers, polysaccharides and others.
Application
- Cardiovascular
- Oncology
- Dermatology
- Neurology
- Others
On the basis of application, the microneedle drug delivery systems market is segmented into cardiovascular, oncology, dermatology, neurology and others.
End users
- Diagnostic Laboratories
- Life Sciences and Research Laboratories
- Hospitals
- Ambulatory Surgical Centers
- Others
Microneedle drug delivery systems market has also been segmented based on the end users into diagnostic laboratories, life sciences and research laboratories, hospitals, ambulatory surgical centers and others.
Microneedle Drug Delivery Systems Market Regional Analysis/Insights
The microneedle drug delivery systems market is analysed and market size insights and trends are provided by country, technology, source type, application and end users as referenced above.
The countries covered in the microneedle drug delivery systems market report are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.
North America dominates the microneedle drug delivery systems market because of the strong base of healthcare facilities, widespread utilization of medications, surging occurrences of chronic diseases such as obesity, high cholesterol, diabetes and heart attacks and rising number of research activities in this region.
Asia-Pacific is expected to witness significant growth during the forecast period of 2022 to 2029 due to the increase in government initiatives to promote awareness, rise in medical tourism, growing research activities in the region, availability of massive untapped markets, large population pool, increasing health conscious people within the region, rise in cases of cardiovascular diseases and the growing demand for quality healthcare in the region.
The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points like down-stream and upstream value chain analysis, technical trends and porter's five forces analysis, case studies are some of the pointers used to forecast the market scenario for individual countries. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.
Healthcare Infrastructure growth Installed base and New Technology Penetration
The microneedle drug delivery systems market also provides you with detailed market analysis for every country growth in healthcare expenditure for capital equipment, installed base of different kind of products for microneedle drug delivery systems market, impact of technology using life line curves and changes in healthcare regulatory scenarios and their impact on the microneedle drug delivery systems market. The data is available for historic period 2010-2020.
Competitive Landscape and Microneedle Drug Delivery Systems Market Share Analysis
The microneedle drug delivery systems market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to microneedle drug delivery systems market.
Some of the major players operating in the microneedle drug delivery systems market are:
- Abbott (US)
- Siemens Healthineers AG (Germany)
- Quidel Corporation (US)
- F. Hoffman-La Roche Ltd. (Switzerland)
- Danaher. (US)
- BD (US)
- Chembio Diagnostics (US)
- EKF Diagnostics (UK)
- Trinity Biotech plc (Ireland)
- Instrumentation Laboratory (US)
- Nova Biomedical（美国）
- PTS Diagnostics（美国）
- Sekisui Diagnostics（美国）
- 赛默飞世尔科技（美国）
- 生物梅里埃公司（法国）
- DiaSorin SpA（意大利）
- AccuBioTech 有限公司 (中国)
- Meridian Bioscience（美国）
- Biocartis Bioscience（欧洲）
- GeneSTAT Molecular Diagnostics, LLC（美国）
- 泰尔茂株式会社 (日本)
- Grifols, SA（西班牙）
研究方法：全球微针药物输送系统 市场
数据收集和基准年分析是使用具有大样本量的数据收集模块进行的。市场数据使用市场统计和连贯模型进行分析和估计。市场份额分析和关键趋势分析也是市场报告中的主要成功因素。如需了解更多信息，请请求分析师致电或下拉询问。
DBMR 研究团队使用的关键研究方法是数据三角测量，涉及数据挖掘、数据变量对市场影响的分析以及主要（行业专家）验证。除此之外，数据模型还包括供应商定位网格、市场时间线分析、市场概览和指南、公司定位网格、公司市场份额分析、测量标准、全球与区域和供应商份额分析。要了解有关研究方法的更多信息，请咨询我们的行业专家 https://www.databridgemarketresearch.com/zh/speak-to-analyst/?dbmr=global-microneedle-drug-delivery-systems-market
SKU-
Get online access to the report on the World's First Market Intelligence Cloud
- Interactive Data Analysis Dashboard
- Company Analysis Dashboard for high growth potential opportunities
- Research Analyst Access for customization & queries
- Competitor Analysis with Interactive dashboard
- Latest News, Updates & Trend analysis
- Harness the Power of Benchmark Analysis for Comprehensive Competitor Tracking
研究方法
Data collection and base year analysis are done using data collection modules with large sample sizes. The stage includes obtaining market information or related data through various sources and strategies. It includes examining and planning all the data acquired from the past in advance. It likewise envelops the examination of information inconsistencies seen across different information sources. The market data is analysed and estimated using market statistical and coherent models. Also, market share analysis and key trend analysis are the major success factors in the market report. To know more, please request an analyst call or drop down your inquiry.
The key research methodology used by DBMR research team is data triangulation which involves data mining, analysis of the impact of data variables on the market and primary (industry expert) validation. Data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Patent Analysis, Pricing Analysis, Company Market Share Analysis, Standards of Measurement, Global versus Regional and Vendor Share Analysis. To know more about the research methodology, drop in an inquiry to speak to our industry experts.
可定制
Data Bridge Market Research is a leader in advanced formative research. We take pride in servicing our existing and new customers with data and analysis that match and suits their goal. The report can be customized to include price trend analysis of target brands understanding the market for additional countries (ask for the list of countries), clinical trial results data, literature review, refurbished market and product base analysis. Market analysis of target competitors can be analyzed from technology-based analysis to market portfolio strategies. We can add as many competitors that you require data about in the format and data style you are looking for. Our team of analysts can also provide you data in crude raw excel files pivot tables (Fact book) or can assist you in creating presentations from the data sets available in the report.
